STCBIO

A New Era Comes When Diabetes Can be Basically Treated Using Cells of Pancreas

– STC Life succeeded in differentiating pluripotent stem cells without side effect into beta-cells of pancreas, for the first time in the world

(SEOUL, SOUTH KOREA) STC Stem Cell Treatment & Research Institute(www.stcstri.com) of STC Life Co., Ltd. (Chairman: Kye Ho Lee) succeeded, after conducting research projects for several years, in differentiating new pluripotent stem cells without side effect into beta-cells that control insulin in pancreas. These new pluripotent stem cells can be differentiated into any tissues or organs without adverse effects.

Scientists at STC Stem Cell Treatment & Research Institute first created new pluripotent stem cells with no adverse effects and induced them to differentiate into beta-cells, and they identified their change into beta-cells 7 days thereafter. Then they identified generation of intact beta-cells by tracing insulin genes that typically appear in beta-cells.

Along with success in differentiation of beta-cells, they also succeeded in differentiating into multiple cells in a short span of time. The research team led by Dr. Lee Sang-Yeon said that they generated beta-cells in these processes for the first time in the world.

The research outcome is expected to be immediately applied to treating diabetes as it shows no adverse effects with outstanding safety.

“With development of technology that can successfully differentiate STC pluripotent stem cells without side effect into beta-cells of pancreas, physicians now can treat basic cause of diseases rather than simply mitigating symptoms,” said Kye Ho Lee, Chairman of STC Life. “As we developed natural substances-based pluripotent stem cells (We refer to as STC EPN : Elicited pluripotent stem cell from natural compound) and technology of differentiating diverse cells using such stem cells, after successfully differentiating beta-cells for nerves, cartilages, liver, bone, fat and pancreas, we will be able to lead the world stem cell market. We will grow as the world top life science company by developing cell therapies with world leading technologies.”

Established in 1989, STC Life is a life science company that concentrates resources on R&D of stem cells, genes related to controlling active oxygen in body (p62), life sciences, and energy water-based agriculture.

STC Life developed Pluripotent stem cell without side effects, the first of its kind in the world, and it obtained a total of 58 patents in Korea and other countries, including 17 patents related with STC Pluripotent stem cells. It is also a therapy-oriented life science company that is treating incurable diseases and down-aging using mesenchymal stem cells at 97.7 B&H Clinic.

With the mission of realizing vision and dream of bringing disease-free healthy life to people and extending lifespan while building a world with no poverty, STC Life will continuously develop new technologies to shape a better future.

Contacts:

STC Life Co., Ltd.

Director, Minsun Oh

+82 2 3438 0653

msoh@stc365.com

膵細胞利用により根本的治療の道が開かれる糖尿病 … STC Life、世界で初めて万能幹細胞から膵細胞への分化に成功

http://www.businesswire.com/news/home/20141209005365/ja/#.VIay19KsW2U

糖尿病，利用胞做根本性治的代已到

http://www.businesswire.com/news/home/20141209005366/zh-CN/#.VIe4D6RxmUk

糖尿病，利用臟細胞做根本性治療的時代已經到來

http://www.businesswire.com/news/home/20141209005397/zh-HK/#.VIe4O6RxmUk

http://www.businesswire.com/news/home/20141209005383/en/Era-Diabetes-Treated-Basically-Cells-Pancreas#.VIe4YKRxmUk